by Roswell Park Comprehensive Cancer Center Credit: Pixabay/CC0 Public Domain A new approach to chimeric antigen receptor T-cell (CAR T) therapy has shown great promise against small cell lung cancer (SCLC) in a preclinical study. The findings cover new ground in our understanding of how CAR T can be employed against solid-tumor cancers, and provide...
by Walter and Eliza Hall Institute This immunofluorescence image shows the presence of a specific subset of T cells (tissue-resident memory T cells, TRM) in the lung of smoker patients. The TRM cells are represented here in aqua and red, the lung airways are depicted in pink, and the cell nuclei are depicted in dark blue....
Megan Brooks April 14, 2023 Air pollution may promote the growth of lung cancer in people who have never smoked by activating normally inactive cells in the lung that harbor cancer-causing mutations, new research indicates. “This work adds to our understanding of the mechanism by which air pollutants promote the earliest stages of lung cancer, particularly in...
By Jane Icke, University of Nottingham Researchers at the University of Nottingham have helped to develop a new tool called “CanPredict,” which is able to identify the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives. Featured...
Share on Pinterest Image credt: Bjarte Rettedal/Getty Images. Lung cancer is the second most common form of cancer worldwide. Each year, around 2 million people receive a lung cancer diagnosis, and 1.8 million people die of the disease. There are two types of lung cancer — small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC)...
Anne Trafton | MIT News Office Publication Date: February 2, 2023 PRESS INQUIRIES Caption: A new MIT study explains why dendritic cells (green) in lymph nodes that drain from the lungs fail to stimulate killer T cells (white) to attack lung tumors.Credits: Courtesy of the researchers Immunotherapy — drug treatment that stimulates the immune system...
by Yale University DFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by seventh edition staging per the protocol (full analysis set). Tick marks indicate censored data. An HR < 1 favors osimertinib. DFS, disease-free survival; HR, hazard ratio;...
Lung cancer is the leading cause of cancer death in the United States and around the world and low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and 80 years old who have a significant history of smoking or currently smoke. Lung cancer screening with LDCT has been shown to reduce deaths from...
by Massachusetts General Hospital Credit: CC0 Public Domain Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and 80 years of age with a significant history of smoking, or who currently smoke. Lung cancer screening...
OKAYAMA UNIVERSITY IMAGE: IN A STUDY BY RESEARCHERS FROM OKAYAMA UNIVERSITY, ACTINIDIA ARGUTA (SARUNASHI) JUICE REDUCED TUMOR NODULES IN CARCINOGEN-EXPOSED MICE CREDIT: SAKAE ARIMOTO‑KOBAYASHI Lung cancer is the leading cause of death in Japan and across the globe. Among all the cancers, lung cancer has one of the lowest five-year survival rates. Smoking tobacco and...
